Pfizer Inc
CIK 78003 · View on SEC EDGAR ↗
- Portfolio value
- $238.8M
- Positions
- 18
- As of
- March 31, 2026 Data as of Q1 2026
#5,441 of 8,643 by 13F value · top 63.0%
Portfolio value QoQ: +2.3% 13F does not disclose cash
- Top 10 holdings weight
- 95.76%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 12
- Effective number of positions
- 6.3
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $0 · sells $55,076,505
Median holding: 7.0 quarters Tracked Q4 2024–Q2 2026 · 65.4% still held
- New positions
- 0
- Increased
- 0
- Decreased
- 3
- Closed
- 1
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Sector breakdown
Healthcare
99.4%
Other/Unmapped
0.6%
Full portfolio 17 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| ALLO Allogene Therapeutics, Inc. - Common Stock | $46,928,245 | 28.05% | 22,032,040 | $-2,864,165 | |||
| CELC Celcuity Inc. - Common Stock | $29,550,417 | 17.66% | 295,652 | $-1,794,608 | |||
| ARVN Arvinas, Inc. - Common Stock | $27,662,520 | 16.54% | 3,457,815 | $-7,261,412 | |||
| PYXS Pyxis Oncology, Inc. - Common Stock | $16,487,769 | 9.86% | 5,952,263 | $8,690,304 | |||
| WVE Wave Life Sciences Ltd. - Ordinary Shares | $10,931,250 | 6.53% | 1,875,000 | $-1,003,125 | |||
| BHVN Biohaven Ltd. Common Shares | $8,004,360 | 4.78% | 505,645 | $3,772,111 | |||
| CRBU Caribou Biosciences, Inc. - Common Stock | $7,879,924 | 4.71% | 4,690,431 | $-469,043 | |||
| SPRO Spero Therapeutics, Inc. - Common Stock | $5,338,906 | 3.19% | 2,362,348 | $-165,365 | |||
| ZNTL Zentalis Pharmaceuticals, Inc. - common stock | $3,853,489 | 2.30% | 953,834 | $1,850,438 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $3,553,775 | 2.12% | 372,904 | $-54,097,861 | Down ×2 | ||
| CRDF Cardiff Oncology, Inc. - Common Stock | $3,014,469 | 1.80% | 2,411,575 | $-723,472 | |||
| ZURA Zura Bio Limited - Class A Ordinary shares | $2,882,799 | 1.72% | 538,841 | $-13,951,955 | Down ×2 | ||
| AGMB AgomAb Therapeutics NV - ADRs representing one common share. | $1,035,750 | 0.62% | 75,000 | $222,000 | |||
| BOLT Bolt Biotherapeutics, Inc. - Common Stock | $133,832 | 0.08% | 31,305 | $-3,284 | |||
| SENS Senseonics Holdings, Inc. - Common Stock | $12,418 | 0.01% | 2,171 | $-1,824 | |||
| NXTC NextCure, Inc. - Common Stock | $11,533 | 0.01% | 7,001 | $-246,585 | Down ×2 | ||
| DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | $2,532 | 0.00% | 247 | $1,067 | |||
| No matches | |||||||
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| PYXS | Price move only | +0 | +$8.7M |
| ARVN | Price move only | +0 | -$7.3M |
| BHVN | Price move only | +0 | +$3.8M |
| ALLO | Price move only | +0 | -$2.9M |
| ZNTL | Price move only | +0 | +$1.9M |
| CELC | Price move only | +0 | -$1.8M |
| WVE | Price move only | +0 | -$1.0M |
| CRDF | Price move only | +0 | -$723K |
| CRBU | Price move only | +0 | -$469K |
| AGMB | Price move only | +0 | +$222K |
3 positions hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| HLN | March 31, 2025 | 197,228,952 | $1,881,564,202 | -5.6% |
| BNTX | Dec. 31, 2025 | 1,658,361 | $163,547,562 | -3.9% |
| TRML | Dec. 31, 2025 | 1,272,214 | $60,849,996 | No longer tracked |
| AKRO | March 31, 2025 | 562,626 | $15,652,255 | No longer tracked |
| ANTX | March 31, 2026 | 715,295 | $815,436 | 74.0% |
| QTTB | June 30, 2026 | 101,618 | $736,731 | 20.8% |
| EPIX | Dec. 31, 2025 | 1,675,000 | $319,925 | No longer tracked |